Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Healthcap in conjunction with investment in Cortendo AB (publ)
Mandate

Vinge advises Healthcap in conjunction with investment in Cortendo AB (publ)

November 03, 2014

Vinge has advised HealthCap VI L.P in connection with the execution of an investment agreement with Cortendo AB (publ) (“Cortendo”). The investment will be effected through a directed new issue of shares to HealthCap and other investors.

The new issue must be approved by a shareholders’ meeting of Cortendo and the meeting is expected to be held on or about 1 December 2014.Cortendo is a Swedish biopharmaceutical company which has its base in the United States.

Vinge’s team consisted of responsible partner Johan Winnerblad and associate Alex Miler.

Related

Vinge advises L5 Navigation in connection with the acquisition of Lundaman Instrument

 L5 Navigation Systems AB has acquired the shares in Lundaman Instrument AB. Lundaman develops and supplies weighing systems for wheel loaders and forklift trucks, focusing on the construction, recycling, industrial and materials handling sectors.
May 13, 2026

Vinge advises Aonic in connection with the issuance of subsequent senior secured bonds of EUR 25 million

 Vinge has advised Aonic AB (publ) in connection with the issuance of subsequent senior secured bonds of EUR 25 million, and parallel written procedure to increase the bond framework to EUR 150 million.
May 12, 2026

Vinge advises Consolid Equity and other sellers on the sale of Sertion to Altor

 Vinge has advised Consolid Equity and other sellers on the sale of the Sertion Group to Altor. In connection with the transaction, entrepreneurs and management will reinvest and remain as key owners, partnering with Altor to accelerate the group’s next phase of growth across existing markets and into new geographies.
May 11, 2026